18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Serum Calcium to Phosphorous (Ca/P) Ratio Is a Simple, Inexpensive, and Accurate Tool in the Diagnosis of Primary Hyperparathyroidism

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Primary hyperparathyroidism (PHPT) diagnosis is challenging and is based on serum calcium (Ca) and parathyroid hormone (PTH). Because serum Ca and phosphorous (P) are inversely related in PHPT, we investigated the diagnostic value of the serum Ca/P ratio in the diagnosis of PHPT. We report a single‐center, case‐controlled, retrospective study including 97 patients with documented PHPT and compared them with those of 96 controls (C). The main outcome measures were: serum PTH, 25‐OH vitamin D, Ca, P, albumin, and creatinine. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the serum Ca/P ratio were calculated. The results were verified using an independent, anonymous set of data extracted from a laboratory database containing over 900 million entries. A total of 35 (36.1%) PHPT patients had normocalcemic PHPT (NCHPT). Ca and PTH were significantly higher in PHPT than in C ( p < 0.0001). P was significantly lower in PHPT than in C ( p < 0.0001). The Ca/P ratio was significantly higher in PHPT than in C ( p < 0.0001). Receiver‐operating characteristic (ROC) curves analyses identified a cutoff of 2.71 (3.5 if Ca and P are expressed in mg/dL) for Ca/P ratio with a sensitivity and specificity of 86% and 87%, respectively ( p < 0.0001), confirmed by the independent, big data approach. In conclusion, Ca/P is a valuable tool for the diagnosis of PHPT and is of superior value compared to serum Ca alone, especially in NCPHT. Because Ca/P is simple, inexpensive, and easily accessible worldwide, this ratio is useful for PHPT diagnosis, especially in laboratory/medical settings relying on limited resources, such as low‐income countries. © 2017 The Authors. JBMR Plus is published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: not found
          • Article: not found

          Diagnostic tests. 1: Sensitivity and specificity.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hyperparathyroidism

            The Lancet, 374(9684), 145-158
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Calcium metabolism in health and disease.

              This brief review focuses on calcium balance and homeostasis and their relationship to dietary calcium intake and calcium supplementation in healthy subjects and patients with chronic kidney disease and mineral bone disorders (CKD-MBD). Calcium balance refers to the state of the calcium body stores, primarily in bone, which are largely a function of dietary intake, intestinal absorption, renal excretion, and bone remodeling. Bone calcium balance can be positive, neutral, or negative, depending on a number of factors, including growth, aging, and acquired or inherited disorders. Calcium homeostasis refers to the hormonal regulation of serum ionized calcium by parathyroid hormone, 1,25-dihydroxyvitamin D, and serum ionized calcium itself, which together regulate calcium transport at the gut, kidney, and bone. Hypercalcemia and hypocalcemia indicate serious disruption of calcium homeostasis but do not reflect calcium balance on their own. Calcium balance studies have determined the dietary and supplemental calcium requirements needed to optimize bone mass in healthy subjects. However, similar studies are needed in CKD-MBD, which disrupts both calcium balance and homeostasis, because these data in healthy subjects may not be generalizable to this patient group. Importantly, increasing evidence suggests that calcium supplementation may enhance soft tissue calcification and cardiovascular disease in CKD-MBD. Further research is needed to elucidate the risks and mechanisms of soft tissue calcification with calcium supplementation in both healthy subjects and CKD-MBD patients.
                Bookmark

                Author and article information

                Contributors
                bruno.madeo@unimore.it
                Journal
                JBMR Plus
                JBMR Plus
                10.1002/(ISSN)2473-4039
                JBM4
                JBMR Plus
                John Wiley and Sons Inc. (Hoboken )
                2473-4039
                02 November 2017
                March 2018
                : 2
                : 2 ( doiID: 10.1002/jbm4.v2.2 )
                : 109-117
                Affiliations
                [ 1 ] Unit of Endocrinology, Department of Internal Medicine, Endocrinology, Metabolism, and Geriatrics Azienda Ospedaliero‐Universitaria di Modena, Ospedale Civile di Baggiovara Modena Italy
                [ 2 ] Department of Laboratory Medicine and Pathological Anatomy Azienda Unità Sanitaria Locale (USL) of Modena Modena Italy
                [ 3 ] Department of Biomedical Metabolic and Neural Sciences University of Modena and Reggio Emilia Modena Italy
                [ 4 ] Center for Genomic Research University of Modena and Reggio Emilia Modena Italy
                Author notes
                [*] [* ] Address correspondence to: Bruno Madeo, MD, PhD, Unit of Endocrinology, Department of Internal Medicine, Endocrinology, Metabolism, and Geriatrics, Azienda Ospedaliero‐Universitaria di Modena, Ospedale Civile di Baggiovara, Via Giardini, 1355, 41126 Modena, Italy. E‐mail: bruno.madeo@ 123456unimore.it

                Article
                JBM410019
                10.1002/jbm4.10019
                6124174
                30283895
                09399d5e-af8f-4336-b52c-3b8a77241014
                © 2017 The Authors. JBMR Plus is published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 09 August 2017
                : 08 September 2017
                : 24 September 2017
                Page count
                Figures: 5, Tables: 4, Pages: 9, Words: 5559
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                jbm410019
                March 2018
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.7.1 mode:remove_FC converted:05.09.2018

                hyperparathyroidism screening,diagnosis,hypercalcemia,hypophosphatemia,parathormone,pth,diagnostic value

                Comments

                Comment on this article